On 12 Nov 2026 Universal Health Services closed at $193.84, -10.8% this year; market cap $11.47bn, P/E 7.8.
Health Care · Health Care Facilities · NYSE · United States
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
| Market cap | $11.47bn |
| P/E (trailing) | 7.8 |
| EPS (TTM) | $24.71 |
| Beta | 1.11 |
| Dividend | $0.80 |
| Dividend yield | 0.41% |
| Ex-dividend date | 1 Sep 2026 |
| Latest report | 27 Oct 2026 |
| Next earnings | — |
| YTD | -10.8% |
| 1Y | -14.8% |
| 3Y | +14.9% |
| 5Y | +8.7% |
| Year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $17.36bn | $1.49bn | $849.25m |
| 2024 | $15.83bn | $1.14bn | $1.12bn |
| 2023 | $14.28bn | $717.79m | $524.74m |
| 2022 | $13.40bn | $675.61m | $262.02m |
| 2021 | $12.64bn | $991.59m | $28.04m |
We publish no single base value for Universal Health Services. Our valuation methods put it between $197.54 and $333.42 a share. The valuation code's reason: no point fair value: the two anchors behind it compound the same growth rate and differ only in how they end — a perpetuity at the terminal rate against a multiple on the final year — so the midpoint between them measures terminal treatment rather than what the business is worth. The published range is the same reading with the false precision removed: read it as the span the method supports, and treat neither edge as a point estimate. See every method
Call and put prices: our price for each next to the market's.
Open in the dashboard · Run a full Desk Run
Data as of 12 Nov 2026. Not investment advice.